Loading company…
ProSciento, based in Chula Vista, California, is a clinical research organization focused on obesity, diabetes, and MASLD/MASH.
Founded in 2003 and headquartered in Chula Vista, US, ProSciento, Inc. provides clinical research services for metabolic diseases, including obesity, diabetes, and MASLD/MASH. Its support covers drug and device development for pharmaceutical and biotech clients in North America, Europe, and Asia-Pacific, typically through project-based contracts with milestone payments. Marcus Hompesch is CEO. In September 2020, 1315 Capital made an investment in the company. The company is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in